Fresenius SE & Co has been granted a patent for a method enabling data communication between a server system and a front-end computing device in a healthcare setting. The method involves creating a secondary interface on the server system for the request and establishing a data connection between the two devices. GlobalData’s report on Fresenius SE & Co gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Fresenius SE & Co KGaA - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Fresenius SE & Co, was a key innovation area identified from patents. Fresenius SE & Co's grant share as of May 2024 was 55%. Grant share is based on the ratio of number of grants to total number of patents.

Method for data communication in healthcare environment using secondary interface

Source: United States Patent and Trademark Office (USPTO). Credit: Fresenius SE & Co KGaA

A recently granted patent (Publication Number: US11997167B2) discloses a method for data communication in a healthcare environment between a server system and a front-end computing device. The method involves the front-end computing device transmitting a request for a data connection to the server system, which then processes the request by dynamically creating a secondary interface dedicated to the request. Information to access this secondary interface is transmitted to the front-end computing device, allowing for the establishment of a data connection between the two devices. The processing also includes verifying authentication and authorization based on the request, with the authentication utilizing a pre-shared key.

Furthermore, the patent details the server system's interaction with an infusion station through a data engine and driver module, as well as communication with the front-end computing device via a virtual device module. The virtual device module stores data structures related to the infusion station, such as pump device identity, status, and capabilities. The system is designed to facilitate efficient data transmission in a healthcare setting, ensuring secure and seamless communication between the server system and front-end computing device. Additionally, the patent includes claims for a system for data communication in a healthcare environment, mirroring the method's steps and emphasizing the creation of a secondary interface for establishing the data connection. The secondary interface is described as an application programming interface with a logical processor, enhancing the system's functionality and adaptability within the healthcare environment.

To know more about GlobalData’s detailed insights on Fresenius SE & Co, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.